Vilin Bio Med confirms no promoter encumbrance in FY26

Vilin Bio Med has confirmed that its promoters and persons acting in concert (PACs) did not create any encumbrance on their shareholding during the financial year ended March 31, 2026. This disclosure was submitted to the National Stock Exchange on April 6, 2026, in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The confirmation assures investors that the pledged status of promoter shares remained unchanged throughout the fiscal year.

The filing detailed the shareholding of 15 individuals categorized as promoters, members of the promoter group, and PACs. The data provides transparency regarding the ownership structure and the specific number of shares held by each member of the promoter group. The total shares held by promoters and the promoter group collectively amount to 90,04,374 shares, while PACs hold 24,000 shares.

Promoter and PAC Shareholding Details

The following table outlines the shareholding distribution among the members of the promoter group and PACs as of the financial year ended March 31, 2026:

SI No	Name of the Member	Category	Number of Shares Holding
1	Shankar Reddy Katireddy	Promoter	17,80,520
2	Srinivasa Reddy Devireddy	Promoter	17,60,838
3	Pravallika Venna	Promoter	13,35,400
4	Allu Ramakrishna Reddy	Promoter	11,12,830
5	Julakanti Naga Avinash Reddy	Promoter	8,90,260
6	Sharaz Shaik	Promoter	5,13,075
7	Mohan Rao Adhi	Promoter	5,05,130
8	Ramesh Reddy Sama	Promoter	4,63,234
9	Jwala Veera Venkata Panduranga Praneeth	Promoter	4,45,130
10	Karunakar Reddy Kundoor	Promoter	2,07,957
11	Tanmayee Reddy Sama	Promoter Group	21,250
12	Anuj Bajpai	Promoter Group	15,000
13	Sneha Bajpai	Promoter Group	9,375
14	Ramiza Shaik	PAC	20,000
15	Shaik Saraf	PAC	4,000

The disclosure was signed by Madhusudhan Yadamakanti Reddy, Managing Director of Vilin Bio Med, and submitted to the exchange for record purposes. The company operates from its registered office in Hyderabad and maintains a manufacturing unit in Roorkee, Haridwar.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.88%	-3.56%	-5.05%	+129.68%	+59.07%	+61.58%

Vilin Bio Med has accepted the resignation of Avula Hariprasad from the position of Chief Financial Officer, effective June 11, 2026. Hariprasad stepped down due to pre-occupation and other commitments requiring his attention. The resignation was tendered with effect from the close of business hours on June 11, 2026.

The disclosure was made to the National Stock Exchange of India in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that there are no other material reasons for the resignation beyond those stated.

Key Management Change Details

The following table outlines the specifics of the managerial change:

Particulars	Details
Name of the Director / KMP	Mr. Avula Hariprasad
Reason for Change	Resignation as the Chief Financial Officer of the Company with effect from closing of the business hours of June 11, 2026
Date of Cessation	June 11, 2026
Brief Profile	Not Applicable

The resignation letter was submitted to the Board of Directors of Vilin Bio Med Limited. Hariprasad expressed gratitude to the Board and management for the support during his tenure and wished the company continued success.